Key result
IV iron may safely relieve symptoms and reduce hospitalizations in stable HF with iron deficiency.
Why the study?
Iron deficiency occurs in over 30% to 50% of patients with stable chronic heart failure and worsens prognosis, representing a potential novel target to improve symptoms and reduce hospitalizations.
Does intravenous iron therapy improve symptoms and reduce hospitalizations in patients with heart failure and iron deficiency?
Design
Review
Authors
Loading...
May support IV iron for QoL in iron-deficient HF; leaves open confirmation on hard outcomes.
Does intravenous iron therapy improve symptoms and reduce hospitalizations in patients with heart failure and iron deficiency?
Intravenous iron therapy is highlighted as a safe and efficacious intervention for symptom relief and potentially reducing hospitalizations in patients with heart failure and iron deficiency.
Rocha et al. (2018) conducted a review in Heart failure. Intravenous iron was evaluated. Iron deficiency affects 30% to 50% of patients with stable chronic heart failure, and intravenous iron may be a safe and efficacious intervention to relieve symptoms and reduce hospitalizations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: